JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB263920

Human DHCR24 knockout A-431 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

DHCR24 KO cell lysate available now. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9 X = 2 bp deletion Frameshift: 99.61%.

View Alternative Names

24-dehydrocholesterol reductase, 3-beta-hydroxysterol delta-24-reductase, DCE, DHC24_HUMAN, Delta(24)-sterol reductase, Desmosterol to cholesterol enzyme, Dhcr24, Diminuto dwarf1 homolog, Diminuto/dwarf1 homolog, KIAA0018, Nbla03646, Seladin-1, Selective AD indicator 1, Selective Alzheimer's Disease Indicator 1

2 Images
Western blot - Human DHCR24 knockout A-431 cell lysate (AB263920)
  • WB

Lab

Western blot - Human DHCR24 knockout A-431 cell lysate (AB263920)

Lane 1 : Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate

Lane 2 : DHCR24 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate

Lane 3 : Hep G2 (Human liver hepatocellular carcinoma cell line) whole cell lysate

Lanes 1 - 3 : Merged signal (red and green). Green - ab181062 observed at 51 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.

ab181062 was shown to react with DHCR24 in wild-type A-431 cells in Western blot Loss of signal was observed when DHCR24 knockout cell line ab262480 (knockout cell lysate ab263920) was used. Wild-type A-431 and DHCR24 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab181062 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 2000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Seladin 1 antibody [EPR10743] (<a href='/en-us/products/primary-antibodies/seladin-1-antibody-epr10743-ab181062'>ab181062</a>) at 1/2000 dilution

Lane 1:

Wild-type A431 whole cell lysate at 20 µg

Lane 2:

DHCR24 knockout A431 whole cell lysate at 20 µg

Lane 2:

Western blot - Human DHCR24 knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-dhcr24-knockout-a-431-cell-line-ab262480'>ab262480</a>)

Lane 3:

HepG2 whole cell lysate at 20 µg

Predicted band size: 60 kDa

Observed band size: 51 kDa

false

Next Generation Sequencing - Human DHCR24 knockout A-431 cell lysate (AB263920)
  • NGS

Supplier Data

Next Generation Sequencing - Human DHCR24 knockout A-431 cell lysate (AB263920)

Knockout achieved by CRISPR/Cas9; X = 2 bp deletion; Frameshift : 99.61%

Key facts

Cell type

A-431

Species or organism

Human

Tissue

Skin

Knockout validation

Next Generation Sequencing,Western blot

Mutation description

Knockout achieved by CRISPR/Cas9 X = 2 bp deletion Frameshift: 99.61%

Disease

Epidermoid Carcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab263920-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human DHCR24 knockout A431 cell lysate", "number":"AB263920-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A-431 cell lysate", "number":"AB263920-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
DHCR24
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Seladin 1 also known as DHCR24 (3β-Hydroxysteroid-Δ24 reductase) is an enzyme with a molecular mass of approximately 54 kDa. It plays a role in cholesterol biosynthesis by catalyzing the reduction of a double bond at the C-24 position in sterol precursors. Seladin 1 is expressed in various tissues with high expression in the brain liver and adrenal gland. The enzyme contributes to the maintenance of cellular cholesterol homeostasis and provides neuroprotective functions.
Biological function summary

Seladin 1 plays an important role in cellular processes particularly in response to oxidative stress. The protein is not part of a larger complex but functions independently to reduce highly reactive oxygen species levels in cells. It helps in maintaining cellular integrity and contributes to the survival of neuronal cells under stress conditions. Additionally it provides resistance to oxidative stress-induced apoptosis by modulating intracellular antioxidative defense mechanisms.

Pathways

Seladin 1 plays an integral role in the cholesterol biosynthesis pathway and is closely associated with the mevalonate pathway. Its activity directly influences the availability of cholesterol and other sterols impacting membrane fluidity and cellular functions dependent on sterol concentrations. The enzyme interacts with related proteins such as HMG-CoA reductase an important regulatory enzyme within the cholesterol synthesis pathway. These interactions ensure that cellular cholesterol levels are well-regulated to meet physiological demands.

Seladin 1 has been implicated in Alzheimer's disease and certain cancers. In Alzheimer's disease a reduction in Seladin 1 expression correlates with increased susceptibility to amyloid-beta toxicity while its overexpression shows a protective effect. This relationship ties Seladin 1 to amyloid precursor protein processing. In some cancers altered Seladin 1 expression affects tumor growth and progression where it may interact with proteins involved in cell survival pathways. This dual role in both neurodegenerative and cancerous conditions highlights the importance of Seladin 1 in human health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com